Assenagon Asset Management
GMED icon

Assenagon Asset Management’s Globus Medical GMED Stock Holding History

Assenagon Asset Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$431K Sell
5,454
-127,216
-96% -$10.8M ﹤0.01% 1086
2026
Q1 		$11.4M Sell
132,670
-133,862
-50% -$12M 0.02% 431
2025
Q4 		$23.3M Buy
266,532
+222,841
+510% +$16.9M 0.03% 339
2025
Q3 		$2.5M Buy
43,691
+313
+0.7% +$18K ﹤0.01% 786
2025
Q2 		$2.56M Sell
43,378
-869
-2% -$56.1K ﹤0.01% 736
2025
Q1 		$3.24M Sell
44,247
-51,651
-54% -$4.27M 0.01% 639
2024
Q4 		$7.93M Buy
95,898
+41,875
+78% +$3.3M 0.01% 565
2024
Q3 		$3.86M Buy
54,023
+1,558
+3% +$110K 0.01% 776
2024
Q2 		$3.59M Buy
+52,465
New +$3.13M 0.01% 725
2024
Q1 		– Sell
-55,853
Closed -$2.98M – 1412
2023
Q4 		$2.98M Sell
55,853
-289,208
-84% -$14.1M 0.01% 786
2023
Q3 		$17.1M Buy
345,061
+21,378
+7% +$1.2M 0.05% 276
2023
Q2 		$19.3M Buy
323,683
+149,005
+85% +$8.49M 0.07% 235
2023
Q1 		$9.89M Buy
+174,678
New +$11.2M 0.04% 388
2022
Q4 		– Sell
-6,655
Closed -$396K – 1395
2022
Q3 		$396K Sell
6,655
-3
-0% -$181 ﹤0.01% 1144
2022
Q2 		$374K Buy
+6,658
New +$438K ﹤0.01% 1284
2022
Q1 		– Sell
-20,360
Closed -$1.47M – 1473
2021
Q4 		$1.47M Sell
20,360
-144,247
-88% -$10.5M ﹤0.01% 934
2021
Q3 		$12.6M Buy
164,607
+98,188
+148% +$7.88M 0.04% 261
2021
Q2 		$5.15M Sell
66,419
-45,794
-41% -$3.26M 0.02% 477
2021
Q1 		$6.92M Buy
112,213
+13,728
+14% +$869K 0.03% 430
2020
Q4 		$6.42M Buy
+98,485
New +$5.66M 0.03% 320
2019
Q4 		– Sell
-19,691
Closed -$1.01M – 832
2019
Q3 		$1.01M Buy
19,691
+8,410
+75% +$401K 0.01% 548
2019
Q2 		$477K Buy
+11,281
New +$490K ﹤0.01% 860

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Assenagon Asset Management's GMED Position: Q2 2026 in Review

Assenagon Asset Management reduced its Globus Medical (GMED) stake by 96% in Q2 2026, selling an estimated $10.8M and leaving 5,454 shares worth $431K. The position accounts for ﹤0.01% of the portfolio, ranked #1086.

Assenagon Asset Management first reported a position in GMED in Q2 2019 and has held it in 22 quarters since. The position peaked at $23.3M in Q4 2025. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Assenagon Asset Management held 5,454 shares of Globus Medical worth $431K as of Q2 2026.
  • Assenagon Asset Management sold 127,216 Globus Medical shares in Q2 2026, an estimated $10.8M.
  • Globus Medical made up ﹤0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #1086 holding.
  • Assenagon Asset Management first reported a position in Globus Medical in Q2 2019 and has held it in 22 quarters since.
  • Assenagon Asset Management's Globus Medical position peaked at $23.3M in Q4 2025.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.